GSEA further linked high EOGT expression to the activation of pro-cancer pathways, including EMT, angiogenesis, inflammatory response, and TNFα signaling via NFκB, while suppressing oxidative phosphorylation (Figure S6), suggesting EOGT’s involvement in multiple oncogenic pathways. Here, NFKB1 is linked to cancer.